61651 Evasc prlng admn prescription agnt add
Surgery
+Add-on
Also known as: additional thrombolysis, prolonged infusion
Percutaneous transluminal infusion of additional or prolonged thrombolytic agent for extended treatment of arterial occlusion.
Clinical Context
Applied when initial infusion inadequate or in multi-vessel disease. Allows flexible dosing strategies.
RVU Breakdown
| Work RVU | 4.14 |
| Practice Expense RVU | 1.19 |
| Malpractice RVU | 1.37 |
| Total RVU | 6.70 |
Est. Medicare Payment
$223.78
National estimate based on 2026 CMS PFS Conversion Factor ($33.40). Actual payment varies by locality (GPCI adjustment).
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.